To ensure that the observed FOXM1 downregulation is not secondary to apoptosis induction but occurs as a consequence of BCR-ABL kinase inhibition, we overexpressed BCL2 in Ph+ ALL cells and thereby abrogated apoptosis induction by TKI32. The gene discussed is BCL2; the disease is acute lymphoblastic leukemia.